Pay in 4 interest-free payments of $6.68 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
"As unsafe and unlawful mass compounding continues, the Wegovy penetration within the cash channel has been lower-than-expected," Novo Nordisk said in its Tuesday morning statement
The most critical metric will no longer be "prescriptions written," but "net price per dose," as the industry adjusts to a lower-margin, higher-volume reality
Stockhorst U, de Fries D, Steingrueber H-J, Scherbaum WA
His weight loss increased significantly once he started taking semaglutide, which may suggest the medication was primarily responsible but its not possible to draw conclusions based on a single person
Another FDA approval was received in December 2022, expanding the use of Wegovy to adolescents aged 12 and older who meet the BMI (Body Mass Index) criteria
US$ 21.86
US$ 25.73
US$ 22.53
